A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.
The Latest
With 16 cancer drugs currently on the FDA's drug shortage list, Jason Westin, MD, the director of Houston-based MD Anderson Cancer Center's Lymphoma Clinical Research Program, section chief for Aggressive Lymphoma, told the Senate Finance Committee Dec. 5 that "providers…
Atlanta-based Piedmont Oncology Institute named Walter Curran Jr., MD, its new chief.
Doris Ranski-Zazula, BSN, RN, was appointed vice president of the Detroit-based Karmanos Cancer Network, part of McLaren Health Care.
Researchers at Santa Monica, Calif.-based Providence Saint John’s Health Center published new findings from a clinical trial that shed light on a possible treatment for a rare spine cancer.
A partnership between Durham, N.C.,-based Duke University School of Medicine and Houston-based University of Texas MD Anderson Cancer Center has led to the early discovery of a potential method that may be capable of protecting bones from damage during cancer…
LSU Health, LCMC Health, Louisiana Cancer Research Center and Tulane University, all based in New Orleans, are collaborating to bring the state's first National Cancer Institute-designated cancer center, but recruitment efforts stand in the way, nola.com reported Dec. 4.
Atlanta-based Emory University has selected Sandra Wong, MD, a surgical oncologist, to lead as the next dean of Emory University School of Medicine and chief academic officer for Emory Healthcare.
The Medical Board of California revoked the license of an oncologist who provided "sham treatment" to 1,000 patients, the San Francisco Chronicle reported Nov. 30.
Patients who have a cancer diagnosis and also struggle to find the financial means to pay for needed oncology services tend to have worse outcomes, according to the Association of Community Cancer Centers. Connecting the dots for those patients is…